Short Description

Galactomannan (GM) is a polysaccharide component of the Aspergillus cell wall released from growing hyphae. Detection of Galactomannan antigen in BAL fluid has special relevance in recipients of Solid Organ Transplants. Monitoring of galactomannan levels can potentially allow initiation of presumptive antifungal therapy before life threatening infection occurs. The test aids in the diagnosis of Invasive Aspergillosis (IA) and assesses response to therapy. Invasive Aspergillosis is reported in 5-20% of cases with prolonged neutropenia, post transplantation and in patients on immunosuppressive therapy. It has a high mortality rate of 50-80% and approximately 30% cases remain undiagnosed and untreated.

PreTest Information

No special preparation required

Detail Description

GALACTOMANNAN (ASPERGILLUS ANTIGEN) BRONCHOALVEOLAR LAVAGE Test Cost - DNA Labs India

Galactomannan (Aspergillus Antigen) Bronchoalveolar Lavage test is a medical test that is used to diagnose Aspergillosis, a fungal infection caused by Aspergillus. This test is performed by taking a sample of the fluid from the lungs, which is then tested for the presence of the Aspergillus antigen. This test is important because Aspergillosis can be life-threatening if left untreated.

Test Cost

The cost of the Galactomannan (Aspergillus Antigen) Bronchoalveolar Lavage test at DNA Labs India is INR 7000.

Symptoms

The symptoms of Aspergillosis can vary depending on the type of infection and where it is located in the body. Some common symptoms include:

• Fever
• Cough
• Chest pain
• Shortness of breath
• Fatigue
• Headache
• Nasal congestion
• Runny nose
• Sinus pain

Diagnosis

The diagnosis of Aspergillosis is usually made by performing a variety of tests, including:

• Blood tests
• Chest X-ray or CT scan
• Sputum culture
• Biopsy
• Galactomannan (Aspergillus Antigen) Bronchoalveolar Lavage test

It is important to see a doctor if you are experiencing any of the symptoms of Aspergillosis. Early diagnosis and treatment can help prevent serious complications.

Galactomannan (GM) is a polysaccharide component of the Aspergillus cell wall released from growing hyphae. Detection of Galactomannan antigen in BAL fluid has special relevance in recipients of Solid Organ Transplants. Monitoring of galactomannan levels can potentially allow initiation of presumptive antifungal therapy before life threatening infection occurs. The test aids in the diagnosis of Invasive Aspergillosis (IA) and assesses response to therapy. Invasive Aspergillosis is reported in 5-20% of cases with prolonged neutropenia, post transplantation and in patients on immunosuppressive therapy. It has a high mortality rate of 50-80% and approximately 30% cases remain undiagnosed and untreated.